Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Nature Medicine|January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemiaSteven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.Nature Genetics|September 8, 2014
Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinomaCarolyn S Lee, Aparna Bhaduri, Angela Mah, et al.Cancer Research|June 28, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of FunctionHaijiao Zhang, Sophie Means, Anna Reister Schultz, et al.Cancer Management and Research|November 23, 2018
NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control studyLene Sofie Granfeldt Østgård, Mette Nørgaard, Lars Pedersen, et al.British Journal of Haematology|March 6, 2018
Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control studyLene S G Østgård, Mette Nørgaard, Lars Pedersen, et al.Cancer Chemotherapy and Pharmacology|November 30, 2023
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human studyCarla Biesdorf, Xiaowen Guan, Satya R Siddani, et al.Leukemia & Lymphoma|May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemiaThomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.Oncotarget|October 13, 2016
Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patientsLene Sofie Granfeldt Østgård, Mette Nørgaard, Henrik Sengeløv, et al.American Journal of Hematology|September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experienceHolbrook E Kohrt, Samit Patel, Michelle Ho, et al.Pageof 13